IALILEPICCQERAA peptide sequence with a monodisperse polyethylene glycol tail clinical trials

Phase 2 Open Label Prospective Dose-Ranging Clinical Trial with Escalation and Expansion Cohorts to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Dosing, and Efficacy of RLS-0071 for the Treatment of Hospitalized Patients with Steroid -Refractory Acute Graft-versus-Host Disease

This study is testing a new drug, RLS-0071, for hospital patients with a serious condition called acute graft-versus-host disease (aGvHD) that hasn't responded to usual steroid treatment. We want to see if it's safe, how well it works, and find the best dose.